Patent · US Active

Composition and methods for treating ischemic wounds and inflammatory conditions

US10980863B2 · kind B2 · utility

0Cited by
4References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 16, 2019
Grant dateApr 20, 2021
Priority date
Expiry dateSep 16, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y402/01001
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods, compositions, and treatment protocols for treating ischemic wounds and inflammatory conditions in a patient. The treatment protocols comprise or consist of using a modified collagen gel (MCG) to promote healing of ischemic wounds and reduce inflammation at the wound site and in other inflammatory conditions. The modified collagen gel comprises generally a dispersion of collagens in an aqueous matrix comprising water and glycerine, where the amount of Type I collagen is greater than the amount of Type II and Type III collagens in the gel.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.